Science · Studies · Signal
Peptide research, explained.
Evidence-based guides, PubMed research, regulatory updates and independent resources for one of the fastest-moving areas in health science.
PubMed-sourced researchUpdated dailyIndependent editorial standards
Popular Peptide Guides
View all guidesThe guide library is the heart of PRN: what each peptide is, what evidence exists, what remains unknown and how regulators classify it.
BPC-157
A synthetic peptide studied in animal models for tissue and tendon healing.
Read guide →TB-500
A synthetic fragment related to Thymosin Beta-4, studied for recovery and tissue repair.
Read guide →Semaglutide
An FDA-approved GLP-1 receptor agonist for type 2 diabetes and chronic weight management.
Read guide →Tirzepatide
An FDA-approved dual GIP/GLP-1 receptor agonist for diabetes and weight management.
Read guide →Retatrutide
An investigational triple hormone-receptor agonist in clinical trials for obesity.
Read guide →GHK-Cu
A copper-binding peptide widely used in skincare and studied for tissue repair.
Read guide →Reader path
Start Here
Choose the right PRN path: guides, supplier standards, Canada resources, GLP-1, PubMed research or the Weekly Brief.
Find your path →Start hereBest of PRN
The essential peptide guides, evidence explainers, supplier standards and Canada resources — organized for readers who want signal fast.
Follow the PRN reading path →New focusPeptide Research in Canada
Understand the Canadian regulatory landscape, laboratory sourcing, testing standards and current peptide research.
Explore Canada resources →Supplier standardsHow we evaluate research suppliers
Testing, COA transparency, research-use compliance and commercial disclosures.
Review supplier criteria →Affiliate pathBest research peptide suppliers in Canada
A Canada-focused supplier comparison that starts with COAs, testing and compliance.
Compare suppliers →Testing guideHow to read a peptide COA
HPLC, mass spectrometry, batch identity, purity claims and the red flags to watch for.
Read the COA guide →GLP-1Research & treatment resources
Semaglutide, tirzepatide, retatrutide, prescription pathways and current studies.
Explore GLP-1 →Latest Research
All ResearchFresh PubMed studies, prioritized around PRN's core subject clusters before the broader peptide feed.
PubMedPubMedPubMedPubMedPubMed
What's Coming Up Next? The Physiology of Gastroparesis and GLP-1 Agonists
Exploring time-varying cardiovascular effects of GLP-1 receptor agonists: A multi-state network meta-analysis of cardiovascular outcome trials
Case Report: GADA-positive type 1 diabetes with diabetic ketoacidosis in a young adult with obesity temporally associated with unsupervised tirzepatide use for weight reduction
Semaglutide (Wegovy) for secondary cardiovascular prevention in adults with an elevated BMI
Disproportionality analysis of ventricular extrasystoles reported with semaglutide in VigiBase and the FDA Adverse Event Monitoring System
Latest News
View all newsA daily news feed for discovery. Major stories should be upgraded with PRN analysis before being treated as SEO pages.
Navigating peptide hype vs. evidence - American Council on Science and Health
Investigating the Broader Research Potential of Bronchogen Across Complex Biological Systems - Capital Press
Volta Peptides Launches U.S. Warehouse, Expands Research Peptide Shipping Across USA and Canada - USA Today
Editorial standard
Signal, not noise.
Peptide Research News uses automation to monitor research, news and channels — but the product is PRN's organization, source hierarchy and editorial judgment. Educational coverage only; never medical advice.